What was the market valuation of the US autism disorder-and-treatment market in 2024?

The market valuation was $1469.5 Million in 2024. Read More

What is the projected market valuation for the US autism disorder-and-treatment market by 2035?

The projected valuation for 2035 is $3148.5 Million. Read More

What is the expected CAGR for the US autism disorder-and-treatment market during the forecast period 2025 - 2035?

The expected CAGR during this period is 7.17%. Read More

Which companies are considered key players in the US autism disorder-and-treatment market?

Key players include Johnson & Johnson, Roche, Pfizer, Novartis, AbbVie, Merck & Co., AstraZeneca, Eli Lilly and Company, and Bristol-Myers Squibb. Read More

What are the market segments for autism disorders in terms of type?

The segments include Autistic Disorder ($800.0 - $1700.0 Million), Asperger Syndrome ($400.0 - $900.0 Million), and Pervasive Developmental Disorder ($269.5 - $548.5 Million). Read More

What treatment types are included in the US autism disorder-and-treatment market?

Treatment types include Applied Behavior Analysis (ABA) ($800.0 - $1700.0 Million), Hyperbaric Oxygen Therapy ($300.0 - $600.0 Million), and Others ($369.5 - $848.5 Million). Read More

What are the drug segments available in the US autism disorder-and-treatment market?

Drug segments include SSRIs ($300.0 - $650.0 Million), Anti-Convulsant ($250.0 - $550.0 Million), and Others ($919.5 - $1948.5 Million). Read More

How does the market for Autistic Disorder compare to Asperger Syndrome in terms of valuation?

The market for Autistic Disorder ranges from $800.0 to $1700.0 Million, significantly higher than Asperger Syndrome, which ranges from $400.0 to $900.0 Million. Read More

What is the potential growth outlook for the US autism disorder-and-treatment market?

The market appears poised for growth, with a projected valuation increase to $3148.5 Million by 2035. Read More

How do the treatment types vary in terms of market valuation?

Applied Behavior Analysis (ABA) shows the highest valuation range of $800.0 - $1700.0 Million, while Hyperbaric Oxygen Therapy ranges from $300.0 to $600.0 Million. Read More

US Autism Disorder and Treatment Market

ID: MRFR/Pharma/14713-HCR

100 Pages

Nidhi Mandole

Last Updated: April 06, 2026

US Autism Disorder and Treatment Market Research Report: Size, Share, Trend Analysis By Types (Autistic, Asperger Syndrome, Pervasive Developmental Disorder, Other), By Treatment Type (Aplied Behavior Analysis (ABA), Hyperbaric Oxygen Therapy, Others) and By Drug (SSRIs, Anti-Convulsant, Others) - Growth Outlook & Industry Forecast 2025 To 2035

US Autism Disorder and Treatment Market

Market Size

Forecast Period2025 - 2035

CAGR (2025 - 2035)7.17%

2024 Market Size$ 1,469.5 Million

2025 Market Size$ 1,574.86 Million

2035 Market Size$ 3,148.5 Million

Key Players

Johnson & Johnson

Roche

Pfizer

Novartis

AbbVie

Merck & Co.

Trends

Increased Focus on Early Intervention
Integration of Technology in Treatment
Expansion of Research Funding

Opportunities

Increased Awareness and Advocacy
Government Initiatives and Funding
Advancements in Therapeutic Approaches

Summary Table of Contents Segmentation Download PDF

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Industrial Automation & Equipment, BY Type (USD Million)
  1. 4.1.1 Autistic Disorder
  2. 4.1.2 Asperger Syndrome
  3. 4.1.3 Pervasive Developmental Disorder
2. 4.2 Industrial Automation & Equipment, BY Treatment Type (USD Million)
  1. 4.2.1 Applied Behavior Analysis (ABA)
  2. 4.2.2 Hyperbaric Oxygen Therapy
  3. 4.2.3 Others
3. 4.3 Industrial Automation & Equipment, BY Drug (USD Million)
  1. 4.3.1 SSRIs
  2. 4.3.2 Anti-Convulsant
  3. 4.3.3 Others
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Industrial Automation & Equipment
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Industrial Automation & Equipment
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Johnson & Johnson (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Roche (CH)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Pfizer (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Novartis (CH)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 AbbVie (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Merck & Co. (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 AstraZeneca (GB)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Eli Lilly and Company (US)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 Bristol-Myers Squibb (US)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 US MARKET ANALYSIS BY TYPE
3. 6.3 US MARKET ANALYSIS BY TREATMENT TYPE
4. 6.4 US MARKET ANALYSIS BY DRUG
5. 6.5 KEY BUYING CRITERIA OF INDUSTRIAL AUTOMATION & EQUIPMENT
6. 6.6 RESEARCH PROCESS OF MRFR
7. 6.7 DRO ANALYSIS OF INDUSTRIAL AUTOMATION & EQUIPMENT
8. 6.8 DRIVERS IMPACT ANALYSIS: INDUSTRIAL AUTOMATION & EQUIPMENT
9. 6.9 RESTRAINTS IMPACT ANALYSIS: INDUSTRIAL AUTOMATION & EQUIPMENT
10. 6.10 SUPPLY / VALUE CHAIN: INDUSTRIAL AUTOMATION & EQUIPMENT
11. 6.11 INDUSTRIAL AUTOMATION & EQUIPMENT, BY TYPE, 2024 (% SHARE)
12. 6.12 INDUSTRIAL AUTOMATION & EQUIPMENT, BY TYPE, 2024 TO 2035 (USD Million)
13. 6.13 INDUSTRIAL AUTOMATION & EQUIPMENT, BY TREATMENT TYPE, 2024 (% SHARE)
14. 6.14 INDUSTRIAL AUTOMATION & EQUIPMENT, BY TREATMENT TYPE, 2024 TO 2035 (USD Million)
15. 6.15 INDUSTRIAL AUTOMATION & EQUIPMENT, BY DRUG, 2024 (% SHARE)
16. 6.16 INDUSTRIAL AUTOMATION & EQUIPMENT, BY DRUG, 2024 TO 2035 (USD Million)
17. 6.17 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY TYPE, 2025-2035 (USD Million)
  2. 7.2.2 BY TREATMENT TYPE, 2025-2035 (USD Million)
  3. 7.2.3 BY DRUG, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

US Autism Disorder and Treatment Market Segmentation

US Autism Disorder and Treatment Market By Type (USD Million, 2025-2035)

Autistic Disorder
Asperger Syndrome
Pervasive Developmental Disorder

US Autism Disorder and Treatment Market By Treatment Type (USD Million, 2025-2035)

Applied Behavior Analysis (ABA)
Hyperbaric Oxygen Therapy
Others

US Autism Disorder and Treatment Market By Drug (USD Million, 2025-2035)

SSRIs
Anti-Convulsant
Others

Certified Researchers

Customize Report

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”